Nutriband (Nasdaq: NTRB), a developer of transdermal pharmaceutical products, signed an exclusive manufacturing agreement with Fleur Marché for its CBD and Botanical Patch lines. Nutriband's wholly owned contract manufacturing subsidiary, Active Intelligence, will act as exclusive manufacturer for the product lines.

Siyata (Nasdaq: SYTA), a global vendor of Push-to-Talk over Cellular (PoC) devices and cellular signal booster systems, is launching its new SD7+ device, integrating rugged mission-critical push-to-talk (PTT) and body camera functionality in a single device. Siyata’s new SD7+ will soon be powered by Visual Labs innovative software, used by public safety, private security and other customers throughout the United States and internationally.

Digital Ally (Nasdaq: DGLY) announced its Law Enforcement division surpassed 200 subscriptions. The Company’s subscription program, which offers agencies flexible payment terms for bodycam and in-car video solutions and services, has been very popular as municipalities continue to deal with tight spending budgets. The subscription program not only provides an opportunity to pay off the units over time, but in many cases, offers packages that require no down payment.

BioVie (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, announced that an abstract characterizing the hospitalization burden of patients with cirrhosis and ascites and receiving treatment via paracentesis has been selected for presentation at The Liver Meeting 2022, the annual meeting of the American Association for the Study of Liver Diseases (AASLD).